Columbia University: Responding to COVID-19 Pandemic
March 20, 2020
March 20, 2020
NEW YORK, MARCH 20 -- Columbia University's Mailman School of Public Health issued the following news:
Patients without symptoms or mild disease often have low viral loads that may evade detection by standard tests. The C3 Test (Center for Infection and Immunity Coronavirus COVID-19 Test) is designed and optimized to be highly sensitive, or able to detect low levels of viral RNA.
CII has a strong track record identifying, tracking, and develop diagnostics for emerging i . . .
Patients without symptoms or mild disease often have low viral loads that may evade detection by standard tests. The C3 Test (Center for Infection and Immunity Coronavirus COVID-19 Test) is designed and optimized to be highly sensitive, or able to detect low levels of viral RNA.
CII has a strong track record identifying, tracking, and develop diagnostics for emerging i . . .